Suppr超能文献

基于血浆和唾液样本评估暗光褪黑素起始时间。

Assessment of dim light melatonin onset based on plasma and saliva samples.

作者信息

Dermanowski Michał Mateusz, Hejduk Arkadiusz, Kuczyńska Julita, Wichniak Adam, Urbańska Agnieszka, Mierzejewski Paweł

机构信息

Department of Pharmacology, Institute of Psychiatry and Neurology, Warsaw, Poland.

Chair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Chronobiol Int. 2022 May;39(5):626-635. doi: 10.1080/07420528.2021.2016796. Epub 2022 Feb 15.

Abstract

Melatonin (MELA) is a nocturnal hormone involved in the regulation of the circadian rhythm. MELA can be detected in plasma and saliva, and its salivary concentration strongly correlates with its plasma concentration. Dim light melatonin onset (DLMO) is considered to be the most accurate objective marker for assessing the circadian phase. The purpose of the study was to establish a method for the determination of MELA in plasma and saliva based on the liquid chromatography with tandem mass spectrometry (LC-MS/MS) and compare DLMO using both plasma and saliva matrices. The validation of the LC-MS/MS methods was performed in accordance with the European Medicines Agency (EMA) guideline. The study was conducted on a group of 21 volunteers, male and females, aged 26-54 years. Plasma and saliva were collected at five time points: between 20:00 and 00:00 hours. The MELA concentration was determined by the LC-MS/MS. The DLMO was considered as the point in time when MELA concentration exceeds 20 pg/mL in plasma and 7 pg/mL in saliva. The correlation coefficient between the plasma and salivary MELA concentration was r = 0.764 ( < .001). The ratio of the plasma/saliva MELA concentrations was 2.87. The mean time of the DLMO in the plasma was 21:30 ± 0:45 hours, and in the saliva was as follows: 21:34 ± 1:00 hours. The correlation between the DLMO, calculated based on the plasma and saliva MELA profiles, was r = 0.679 ( < .05). The determination of salivary MELA concentration using LC-MS/MS allows for the determination of the DLMO. Our method may be applied in clinical practice for the diagnosis and monitoring of circadian rhythm disorders. CE: Collision Energy; CID: Collision-Induced Dissociation; DL: Desolvation Module; DLMO: Dim Light Melatonin Onset; EFSA: European Food Safety Authority; EMA: European Medicines Agency; ESI: electrospray ionization; HB: heat block; HPLC: high performance liquid chromatography; IS: internal standard; KEDTA: ethylenediaminetetraacetic acid tripotassium salt; LC-MS/MS: liquid chromatography with tandem mass spectrometry; LLE: liquid-liquid extraction; LLOQ: lower limit of quantification; MELA: melatonin; MELA-D: melatonin-d; MRM: multiple reaction monitoring; Q1: quadrupole 1; Q3: quadrupole 3; RE: relative error; RIA: radioimmunoassay; RSD: relative standard deviation; SD: standard deviation; ULOQ: upper limit of quantification.

摘要

褪黑素(MELA)是一种参与昼夜节律调节的夜间激素。血浆和唾液中均可检测到MELA,其唾液浓度与血浆浓度密切相关。暗光褪黑素起始(DLMO)被认为是评估昼夜节律阶段最准确的客观指标。本研究的目的是建立一种基于液相色谱-串联质谱法(LC-MS/MS)测定血浆和唾液中MELA的方法,并比较使用血浆和唾液基质的DLMO。LC-MS/MS方法的验证按照欧洲药品管理局(EMA)指南进行。该研究对一组21名年龄在26 - 54岁之间的志愿者(男女均有)进行。在五个时间点(20:00至00:00之间)采集血浆和唾液。通过LC-MS/MS测定MELA浓度。DLMO被定义为血浆中MELA浓度超过20 pg/mL且唾液中超过7 pg/mL的时间点。血浆和唾液中MELA浓度的相关系数为r = 0.764(<0.001)。血浆/唾液MELA浓度之比为2.87。血浆中DLMO的平均时间为21:30±0:45小时,唾液中的为:21:34±1:00小时。基于血浆和唾液MELA谱计算的DLMO之间的相关性为r = 0.679(<0.05)。使用LC-MS/MS测定唾液中MELA浓度可确定DLMO。我们的方法可应用于临床实践中昼夜节律紊乱的诊断和监测。CE:碰撞能量;CID:碰撞诱导解离;DL:去溶剂化模块;DLMO:暗光褪黑素起始;EFSA:欧洲食品安全局;EMA:欧洲药品管理局;ESI:电喷雾电离;HB:加热块;HPLC:高效液相色谱;IS:内标;KEDTA:乙二胺四乙酸三钾盐;LC-MS/MS:液相色谱-串联质谱法;LLE:液-液萃取;LLOQ:定量下限;MELA:褪黑素;MELA-D:褪黑素-d;MRM:多反应监测;Q1:四极杆1;Q3:四极杆3;RE:相对误差;RIA:放射免疫分析;RSD:相对标准偏差;SD:标准偏差;ULOQ:定量上限。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验